Cargando…

Treatment resistant depression in women with peripartum depression

BACKGROUND: Peripartum depression is a leading cause of disease burden for women and yet there is little evidence as to how often peripartum depression does not respond to treatment and becomes treatment resistant depression. We sought to determine the incidence of treatment resistant depression (TR...

Descripción completa

Detalles Bibliográficos
Autores principales: Cepeda, M. Soledad, Kern, David M., Nicholson, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721276/
https://www.ncbi.nlm.nih.gov/pubmed/31477032
http://dx.doi.org/10.1186/s12884-019-2462-9
_version_ 1783448308693336064
author Cepeda, M. Soledad
Kern, David M.
Nicholson, Susan
author_facet Cepeda, M. Soledad
Kern, David M.
Nicholson, Susan
author_sort Cepeda, M. Soledad
collection PubMed
description BACKGROUND: Peripartum depression is a leading cause of disease burden for women and yet there is little evidence as to how often peripartum depression does not respond to treatment and becomes treatment resistant depression. We sought to determine the incidence of treatment resistant depression (TRD) in women with peripartum depression. METHODS: Population based retrospective cohort study using a large US claims database. Peripartum depression was defined as having a depression diagnosis during pregnancy or up to 6 months after the end of pregnancy. We included women with prevalent or incident depression. The outcome was the development of TRD within 1 year after the diagnosis of peripartum depression. TRD was defined as having 3 distinct antidepressants or 1 antidepressant and 1 antipsychotic in 1 year. Women with peripartum depression may not be exposed to pharmacological treatments early in pregnancy, therefore we created two groups: 1. women with peripartum depression, and 2. women with peripartum depression diagnosed 3 months before a live birth delivery or within 6 months after that delivery. RESULTS: There were 3,207,684 pregnant women, of whom 2.5% had peripartum depression. Of these women half had incident depression during pregnancy. Five percent of women with peripartum depression developed TRD within 1 year of the depression diagnosis. The risk of developing TRD was 50% higher in women with prevalent depression than in women with incident peripartum depression (P < 0.0001). Results were similar in women with peripartum depression diagnosed later in their pregnancy. Women who went on to develop TRD had more substance use disorders, anxiety, insomnia and painful conditions. CONCLUSIONS: TRD occurs in approximately 5% of women with peripartum depression. The risk of TRD is higher in pregnant women with a history of depression. Women who went on to develop TRD had more psychiatric comorbidities and painful conditions than women who did not. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12884-019-2462-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6721276
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-67212762019-09-10 Treatment resistant depression in women with peripartum depression Cepeda, M. Soledad Kern, David M. Nicholson, Susan BMC Pregnancy Childbirth Research Article BACKGROUND: Peripartum depression is a leading cause of disease burden for women and yet there is little evidence as to how often peripartum depression does not respond to treatment and becomes treatment resistant depression. We sought to determine the incidence of treatment resistant depression (TRD) in women with peripartum depression. METHODS: Population based retrospective cohort study using a large US claims database. Peripartum depression was defined as having a depression diagnosis during pregnancy or up to 6 months after the end of pregnancy. We included women with prevalent or incident depression. The outcome was the development of TRD within 1 year after the diagnosis of peripartum depression. TRD was defined as having 3 distinct antidepressants or 1 antidepressant and 1 antipsychotic in 1 year. Women with peripartum depression may not be exposed to pharmacological treatments early in pregnancy, therefore we created two groups: 1. women with peripartum depression, and 2. women with peripartum depression diagnosed 3 months before a live birth delivery or within 6 months after that delivery. RESULTS: There were 3,207,684 pregnant women, of whom 2.5% had peripartum depression. Of these women half had incident depression during pregnancy. Five percent of women with peripartum depression developed TRD within 1 year of the depression diagnosis. The risk of developing TRD was 50% higher in women with prevalent depression than in women with incident peripartum depression (P < 0.0001). Results were similar in women with peripartum depression diagnosed later in their pregnancy. Women who went on to develop TRD had more substance use disorders, anxiety, insomnia and painful conditions. CONCLUSIONS: TRD occurs in approximately 5% of women with peripartum depression. The risk of TRD is higher in pregnant women with a history of depression. Women who went on to develop TRD had more psychiatric comorbidities and painful conditions than women who did not. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12884-019-2462-9) contains supplementary material, which is available to authorized users. BioMed Central 2019-09-02 /pmc/articles/PMC6721276/ /pubmed/31477032 http://dx.doi.org/10.1186/s12884-019-2462-9 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Cepeda, M. Soledad
Kern, David M.
Nicholson, Susan
Treatment resistant depression in women with peripartum depression
title Treatment resistant depression in women with peripartum depression
title_full Treatment resistant depression in women with peripartum depression
title_fullStr Treatment resistant depression in women with peripartum depression
title_full_unstemmed Treatment resistant depression in women with peripartum depression
title_short Treatment resistant depression in women with peripartum depression
title_sort treatment resistant depression in women with peripartum depression
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721276/
https://www.ncbi.nlm.nih.gov/pubmed/31477032
http://dx.doi.org/10.1186/s12884-019-2462-9
work_keys_str_mv AT cepedamsoledad treatmentresistantdepressioninwomenwithperipartumdepression
AT kerndavidm treatmentresistantdepressioninwomenwithperipartumdepression
AT nicholsonsusan treatmentresistantdepressioninwomenwithperipartumdepression